KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Short-term Investments (2020 - 2025)

Neogenomics filings provide 6 years of Short-term Investments readings, the most recent being $9.0 million for Q2 2025.

  • On a quarterly basis, Short-term Investments fell 72.65% to $9.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $9.0 million, a 72.65% decrease, with the full-year FY2024 number at $19.8 million, down 72.73% from a year prior.
  • Short-term Investments hit $9.0 million in Q2 2025 for Neogenomics, down from $11.9 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $203.0 million in Q2 2021 to a low of $9.0 million in Q2 2025.
  • Median Short-term Investments over the past 5 years was $131.3 million (2023), compared with a mean of $116.0 million.
  • Biggest five-year swings in Short-term Investments: surged 301.28% in 2021 and later plummeted 77.54% in 2025.
  • Neogenomics' Short-term Investments stood at $198.6 million in 2021, then dropped by 11.96% to $174.8 million in 2022, then tumbled by 58.4% to $72.7 million in 2023, then crashed by 72.73% to $19.8 million in 2024, then tumbled by 54.81% to $9.0 million in 2025.
  • The last three reported values for Short-term Investments were $9.0 million (Q2 2025), $11.9 million (Q1 2025), and $19.8 million (Q4 2024) per Business Quant data.